Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: 69408-81-7, Nafidimide, Quinamed, Benzisoquinolinedione, Xanafide, 5-aminomitonafide
Molecular Formula
C16H17N3O2
Molecular Weight
283.32  g/mol
InChI Key
UPALIKSFLSVKIS-UHFFFAOYSA-N
FDA UNII
1Q8D39N37L

Amonafide is an imide derivative of naphthalic acid. Amonafide intercalates into DNA and inhibits topoisomerase II, resulting in protein-associated strand breaks and impaired DNA and RNA synthesis.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
5-amino-2-[2-(dimethylamino)ethyl]benzo[de]isoquinoline-1,3-dione
2.1.2 InChI
InChI=1S/C16H17N3O2/c1-18(2)6-7-19-15(20)12-5-3-4-10-8-11(17)9-13(14(10)12)16(19)21/h3-5,8-9H,6-7,17H2,1-2H3
2.1.3 InChI Key
UPALIKSFLSVKIS-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CN(C)CCN1C(=O)C2=CC=CC3=CC(=CC(=C32)C1=O)N
2.2 Other Identifiers
2.2.1 UNII
1Q8D39N37L
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 5-amino-2-(2-(dimethylamino)ethyl)-1h-benz(de)isoquinoline-1,3(2h)-dione

2. 5-amino-2-(2-dimethylaminoethyl)benzo(de)isoquinolin-1,3-dione

3. Benzisoquinolinedione

4. Fa 142

5. M-fa 142

6. M-fa-142

7. Mfa 142

8. Mfa-142

9. Nafidimide

10. Nsc 308847

11. Nsc-308847

2.3.2 Depositor-Supplied Synonyms

1. 69408-81-7

2. Nafidimide

3. Quinamed

4. Benzisoquinolinedione

5. Xanafide

6. 5-aminomitonafide

7. Nsc-308847

8. As1413

9. M-fa 142

10. Fa 142

11. Nsc308847

12. As-1413

13. 3-amino-n-(2-(dimethylamino)ethyl)naphthalimide

14. 5-amino-2-[2-(dimethylamino)ethyl]benzo[de]isoquinoline-1,3-dione

15. Mls000757039

16. Chembl428676

17. Amonifide

18. 1q8d39n37l

19. Amonafide (usan)

20. 1h-benz(de)isoquinoline-1,3(2h)-dione, 5-amino-2-(2-(dimethylamino)ethyl)-

21. Naphthalimide, 3-amino-n-(2-(dimethylamino)ethyl)-

22. Amonafide [usan]

23. 5-amino-2-(2-(dimethylamino)ethyl)-1h-benzo[de]isoquinoline-1,3(2h)-dione

24. Amonafide [inn]

25. Amonafidum [latin]

26. Amonafida [spanish]

27. Amonafidum

28. Amonafida

29. Smr000528907

30. Amonafide [usan:inn]

31. As-1413(amonafide)

32. Nsc 308847

33. Brn 5344673

34. Amonofide

35. Unii-1q8d39n37l

36. 5-amino-2-[2-(dimethylamino)ethyl]-1h-benzo[de]isoquinoline-1,3(2h)-dione

37. Amonafide-[d6]

38. M-fa-142

39. Bida

40. 3-amino-n-(2-(dimethylamino)ethyl)-1,8-naphthalindicarboximid

41. Amonafide [mart.]

42. 1h-benz(de)isoquinoline-1,3(2h)-dione, 5-amino-2-(dimethylamino)ethyl-

43. Ncimech_000383

44. Amonafide [who-dd]

45. Schembl27226

46. Mls006010419

47. Mls006011267

48. Chebi:94661

49. Cgx-571

50. Dtxsid30219562

51. Hms3654h19

52. 5-amino-2-(2-dimethylaminoethyl)benzo[de]isoquinoline-1,3-dione

53. Zinc4214836

54. Bdbm50033894

55. Ccg-35694

56. Nsc758251

57. S1367

58. Akos015850731

59. Bcp9000321

60. Cs-0496

61. Db05022

62. Nci-308847

63. Nsc-758251

64. Nsc308847,as1413

65. Ncgc00346513-01

66. Ac-22581

67. As-56124

68. Hy-10982

69. Nci60_002643

70. Ft-0662118

71. Sw219946-1

72. A24926

73. D10090

74. 408a817

75. Q4747531

76. Brd-k56334280-001-02-8

77. Brd-k56334280-001-03-6

78. 1h-benz[de]isoquinoline-1, 5-amino-2-[2-(dimethylamino)ethyl]-

79. 5-amino-2-(2-dimethylamino-ethyl)-benzo[de]isoquinoline-1,3-dione

80. 1h-benz[de]isoquinoline-1,3(2h)-dione,5-amino-2-[2-(dimethylamino)ethyl]-

81. 5-amino-2-(2-dimethylamino-ethyl)-benzo[de]isoquinoline-1,3-dione (amonafide)

82. 5-amino-2-(2-dimethylamino-ethyl)-benzo[de]isoquinoline-1,3-dione(amonafide)

83. 5-amino-2-[2-(dimethylamino)ethyl]-1h-benz[de]isoquinoline-1,3(2h)-dione;amonafide.

84. 5-amino-2-[2-(dimethylamino)ethyl]-1h-benzo[de]isoquinoline-1,3(2h)-dione #

85. 11-amino-3-[2-(dimethylamino)ethyl]-3-azatricyclo[7.3.1.0?,??]trideca-1(13),5,7,9,11-pentaene-2,4-dione

86. Amonafidedihydrochloride,1h-benz[de]isoquinoline-1,3(2h)-dione,5-amino-2-[2-(dimethylamino)ethyl]-

2.4 Create Date
2005-03-26
3 Chemical and Physical Properties
Molecular Weight 283.32 g/mol
Molecular Formula C16H17N3O2
XLogP31.5
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count4
Rotatable Bond Count3
Exact Mass283.132076794 g/mol
Monoisotopic Mass283.132076794 g/mol
Topological Polar Surface Area66.6 Ų
Heavy Atom Count21
Formal Charge0
Complexity437
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Investigated for use/treatment in breast cancer, ovarian cancer, and prostate cancer.


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Antiviral Agents

Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)


Antineoplastic Agents

Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)


Enzyme Inhibitors

Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)


Intercalating Agents

Agents that are capable of inserting themselves between the successive bases in DNA, thus kinking, uncoiling or otherwise deforming it and therefore preventing its proper functioning. They are used in the study of DNA. (See all compounds classified as Intercalating Agents.)


5.2 Mechanism of Action

Amonafide is a DNA intercalating agent and inhibitor of topoisomerase II that has been extensively studied in patients with malignant solid tumors. Amonafide has also been studied in patients with AML.